Background The Fisher to Lewis (F-L) model of renal transplantation (Rtx) is widely used. Rtx from F to L without immunosuppressive treatment results in 50% survival, whereas L to F results in survival rates similar to syngrafts. When treated with an angiotensin-converting enzyme (ACE) inhibitor or antihypertensive triple therapy, renal damage is markedly reduced in F-L allografts. Despite similar reductions in blood pressure, the ACE inhibitor (ACE-I) is more effective than antihypertensive triple therapy, suggesting that the inhibition of intrarenal ACE plays an additional role in the attenuation of renal damage.Methods In the present study, we investigated strain-related differences in intrarenal ACE activity between F and L rats and whe...
Post-transplant hypertension in the rat: Effects of captopril and native nephrectomy. In patients wi...
Background. Chronic allograft dysfunction (CAD), the major cause of the failure of kidney allografts...
Proteinuria plays a pathogenic role in the development of end stage renal disease. Angiotensin conve...
Background The Fisher to Lewis (F-L) model of renal transplantation (Rtx) is widely used. Rtx from F...
Abstract Introduction: Hypertension is nearly universal in kidney transplant and several factors ar...
Background. Blockade of the renin-angiotensin system (RAS) with angiotensin-converting enzyme (ACE) ...
In renal transplantation, chronic renal transplant failure (CRTF) is the principal cause of late gra...
Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft ...
Long-term renin-angiotensin system blockade is beneficial in a variety of renal diseases, This study...
One of the most intriguing features in kidney transplantation is the finding that kidneys from hyper...
Effects of kidney transplantation on the renin-angiotensin systems of the recipients. To investigate...
ACE inhibition limits chronic injury of kidney transplant even with treatment started when lesions a...
Background. In man, differences in angiotensin converting enzyme (ACE) levels, related to ACE (I/D) ...
INTRODUCTION: Ace b/l polymorphism in rats is associated with differential tissue angiotensin-conver...
Introduction: Ace b/l polymorphism in rats is associated with differential tissue angiotensin-conver...
Post-transplant hypertension in the rat: Effects of captopril and native nephrectomy. In patients wi...
Background. Chronic allograft dysfunction (CAD), the major cause of the failure of kidney allografts...
Proteinuria plays a pathogenic role in the development of end stage renal disease. Angiotensin conve...
Background The Fisher to Lewis (F-L) model of renal transplantation (Rtx) is widely used. Rtx from F...
Abstract Introduction: Hypertension is nearly universal in kidney transplant and several factors ar...
Background. Blockade of the renin-angiotensin system (RAS) with angiotensin-converting enzyme (ACE) ...
In renal transplantation, chronic renal transplant failure (CRTF) is the principal cause of late gra...
Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft ...
Long-term renin-angiotensin system blockade is beneficial in a variety of renal diseases, This study...
One of the most intriguing features in kidney transplantation is the finding that kidneys from hyper...
Effects of kidney transplantation on the renin-angiotensin systems of the recipients. To investigate...
ACE inhibition limits chronic injury of kidney transplant even with treatment started when lesions a...
Background. In man, differences in angiotensin converting enzyme (ACE) levels, related to ACE (I/D) ...
INTRODUCTION: Ace b/l polymorphism in rats is associated with differential tissue angiotensin-conver...
Introduction: Ace b/l polymorphism in rats is associated with differential tissue angiotensin-conver...
Post-transplant hypertension in the rat: Effects of captopril and native nephrectomy. In patients wi...
Background. Chronic allograft dysfunction (CAD), the major cause of the failure of kidney allografts...
Proteinuria plays a pathogenic role in the development of end stage renal disease. Angiotensin conve...